It is not crazy to connect cholesterol-modifying drugs with cognition; after all, one quarter of the body's cholesterol is found in the brain.
把调整胆固醇的药物和认知联合起来并不荒唐;毕竟,人体的四分之一的胆固醇位于大脑。
In the past decade researchers have begun modifying genetic material for applications like drugs and the growth of fuels.
在过去的10年间,研究者们开始针对药物和燃料增长的应用来改变遗传物质。
Therefore, substantial revenue opportunity for conventional disease-modifying antirheumatic drugs (DMARDs) remains in early lines of therapy.
因此,在早期治疗中,常规抗风湿性关节炎疾病缓解用药还有很大市场。
应用推荐